Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) — Market Cap & Net Worth
Market Cap & Net Worth: Shanxi C&Y Pharmaceutical Group Co Ltd (300254)
Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) has a market capitalization of $332.73 Million (CN¥2.27 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #14427 globally and #4310 in its home market, demonstrating a -7.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanxi C&Y Pharmaceutical Group Co Ltd's stock price CN¥8.88 by its total outstanding shares 256058563 (256.06 Million). Review Shanxi C&Y Pharmaceutical Group Co Ltd total liabilities to assess the company's total debt and financial obligations.
Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap History: 2015 to 2026
Shanxi C&Y Pharmaceutical Group Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.08 Billion to $332.73 Million (-9.27% CAGR).
Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.44x
Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 0.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
15.26x
Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 15.26 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $714.17 Million | $746.08 Million | $30.15 Million | 0.96x | 23.69x |
| 2017 | $383.10 Million | $938.93 Million | $21.67 Million | 0.41x | 17.68x |
| 2018 | $242.17 Million | $1.14 Billion | $7.24 Million | 0.21x | 33.44x |
| 2019 | $303.88 Million | $1.13 Billion | $5.30 Million | 0.27x | 57.37x |
| 2020 | $258.16 Million | $848.07 Million | -$262.37 Million | 0.30x | N/A |
| 2021 | $325.61 Million | $930.37 Million | -$91.44 Million | 0.35x | N/A |
| 2022 | $253.67 Million | $829.00 Million | -$118.52 Million | 0.31x | N/A |
| 2023 | $360.83 Million | $799.31 Million | $25.20 Million | 0.45x | 14.32x |
| 2024 | $327.86 Million | $846.61 Million | $42.19 Million | 0.39x | 7.77x |
| 2025 | $379.19 Million | $870.79 Million | $24.85 Million | 0.44x | 15.26x |
Competitor Companies of 300254 by Market Capitalization
Companies near Shanxi C&Y Pharmaceutical Group Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Shanxi C&Y Pharmaceutical Group Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Shanxi C&Y Pharmaceutical Group Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shanxi C&Y Pharmaceutical Group Co Ltd's market cap moved from $1.08 Billion to $ 332.73 Million, with a yearly change of -9.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥332.73 Million | -12.25% |
| 2025 | CN¥379.19 Million | +15.66% |
| 2024 | CN¥327.86 Million | -9.14% |
| 2023 | CN¥360.83 Million | +42.25% |
| 2022 | CN¥253.67 Million | -22.09% |
| 2021 | CN¥325.61 Million | +26.12% |
| 2020 | CN¥258.16 Million | -15.04% |
| 2019 | CN¥303.88 Million | +25.48% |
| 2018 | CN¥242.17 Million | -36.79% |
| 2017 | CN¥383.10 Million | -46.36% |
| 2016 | CN¥714.17 Million | -34.12% |
| 2015 | CN¥1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Shanxi C&Y Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $332.73 Million USD |
| MoneyControl | $332.73 Million USD |
| MarketWatch | $332.73 Million USD |
| marketcap.company | $332.73 Million USD |
| Reuters | $332.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanxi C&Y Pharmaceutical Group Co Ltd
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, comme… Read more